A novel germline BRCA2 mutation in a Chinese patient with prostate cancer sensitive to platinum chemotherapy: a case report

A novel germline BRCA2 mutation in a Chinese patient with prostate cancer sensitive to platinum chemotherapy: a case report

Abstract Background Germline BRCA2 mutation is associated with an aggressive prostate cancer phenotype and indicates higher risk for hereditary cancer. Recently, numerous studies have attempted to identify the genomic landscape of prostate cancer to better understand the genomic drivers of this dise...

Full description

Bibliographic Details
Main Authors: Lijuan Jiang, Zunguang Bai, Shoulun Zhu, Tingting Zhao, Yining Yang, Zhiyong Li, Dong Chen, Zhiming Wu, Yanjun Wang, Fangjian Zhou, Yonghong Li
Format: Article
Language:English
Published: BMC 2021-08-01
Series:BMC Urology
Subjects:
Prostate cancer
BRCA2
Family history
Platinum chemotherapy
Online Access:https://doi.org/10.1186/s12894-021-00879-4

Internet

https://doi.org/10.1186/s12894-021-00879-4

Similar Items